comparemela.com

Latest Breaking News On - Lyra therapeutics - Page 19 : comparemela.com

Lyra Therapeutics closes $100 5M private placement

Lyra Therapeutics (Nasdaq:LYRA) announced today that it closed its previously announced private placement worth $100.5 million.

Lyra therapeutics

Lyra Therapeutics closes $100 5M private placement - Drug Delivery Business

Lyra Therapeutics (Nasdaq:LYRA) announced today that it closed its previously announced private placement worth $100.5 million.

Harlanw waksalNantahala capital managementLyra therapeuticsTherapeutics executive chairVenrock healthcare capital partnersSamsara biocapitalPerceptive advisorsNorth bridge venture partnersPura vida investmentsMassachusetts based lyra therapeutics

Lyra Therapeutics Announces $100 5 Million Private Placement

/PRNewswire/ Lyra Therapeutics, Inc. (Nasdaq: LYRA) today announced that it has entered into a securities purchase agreement to sell securities in a private.

United statesKathryn morrisPrnewswire lyra therapeutics incLyra therapeutics incSecurities actPrivate securities litigation reform actAnnual reportLyra therapeutics

Lyra Therapeutics announces $100 5M private placement

Lyra Therapeutics announced today that it entered into an agreement to sell securities in a private placement worth more than 100 million.

Lyra therapeutics

Lyra Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Corporate Update

/PRNewswire/ Lyra Therapeutics, Inc. (Nasdaq: LYRA), a clinical-stage therapeutics company leveraging its proprietary XTreo™ platform to enable precise,.

United statesAppointedjim tobinKathryn morrisMaria palasisHarlanw waksalBoston scientific corporationCompany board of directorsBaxter internationalBiogen incMeeting of the american rhinologic societyLyra therapeutics incBoard at transmedics incLyra therapeuticsChief executive officerCombined otolaryngology spring meetingsFourth quarter

vimarsana © 2020. All Rights Reserved.